Published in Infect Immun on August 01, 2005
Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog (2008) 3.91
Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol (2007) 2.90
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev (2008) 2.47
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother (2007) 2.10
Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun (2009) 1.86
Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect Immun (2006) 1.58
Gentamicin promotes Staphylococcus aureus biofilms on silk suture. J Surg Res (2011) 1.53
Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus. MBio (2012) 1.51
Staphylococcus aureus CcpA affects biofilm formation. Infect Immun (2008) 1.37
Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilm-associated foreign-body infections. Infect Immun (2009) 1.32
Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother (2006) 1.30
Quorum-sensing regulation governs bacterial adhesion, biofilm development, and host colonization in Pantoea stewartii subspecies stewartii. Proc Natl Acad Sci U S A (2006) 1.19
Bacterial contamination of surgical suture resembles a biofilm. Surg Infect (Larchmt) (2010) 1.15
Fibrinogen induces biofilm formation by Streptococcus suis and enhances its antibiotic resistance. Appl Environ Microbiol (2008) 1.10
Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. J Antibiot (Tokyo) (2011) 1.03
Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system. Infect Immun (2008) 1.01
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis (2012) 0.97
The Staphylococcus aureus GGDEF domain-containing protein, GdpS, influences protein A gene expression in a cyclic diguanylic acid-independent manner. Infect Immun (2009) 0.96
Relation between antibiotic susceptibility and ultrastructure of Staphylococcus aureus biofilms on surgical suture. Surg Infect (Larchmt) (2011) 0.94
Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery. Curr Protoc Pharmacol (2010) 0.93
A coverslip-based technique for evaluating Staphylococcus aureus biofilm formation on human plasma. Front Cell Infect Microbiol (2012) 0.90
A Serratia marcescens PigP homolog controls prodigiosin biosynthesis, swarming motility and hemolysis and is regulated by cAMP-CRP and HexS. PLoS One (2013) 0.90
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrol Dial Transplant (2009) 0.89
Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob Agents Chemother (2013) 0.89
Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomedicine (2012) 0.88
Update on ureteral stent technology. Ther Adv Urol (2009) 0.87
Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials (2015) 0.87
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation. Antimicrob Agents Chemother (2009) 0.86
Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob Agents Chemother (2012) 0.86
Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation. PLoS One (2012) 0.86
A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. Antimicrob Agents Chemother (2011) 0.85
In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells. Antimicrob Agents Chemother (2011) 0.85
The Use of Commercially Available Alpha-Amylase Compounds to Inhibit and Remove Staphylococcus aureus Biofilms. Open Microbiol J (2011) 0.85
Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells. Infect Immun (2006) 0.84
Structure and function of Pseudomonas aeruginosa protein PA1324 (21-170). Protein Sci (2009) 0.84
Components of the cultivated red seaweed Chondrus crispus enhance the immune response of Caenorhabditis elegans to Pseudomonas aeruginosa through the pmk-1, daf-2/daf-16, and skn-1 pathways. Appl Environ Microbiol (2013) 0.83
Ureteral stent symptoms and associated infections: a biomaterials perspective. Nat Rev Urol (2009) 0.82
Interplay of antibiotics and bacterial inoculum on suture-associated biofilms. J Surg Res (2012) 0.82
Does the heparin lock concentration affect hemodialysis catheter patency? Clin J Am Soc Nephrol (2010) 0.82
How to deal with dialysis catheters in the ICU setting. Ann Intensive Care (2012) 0.82
Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients. Int J Nephrol Renovasc Dis (2014) 0.82
Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. J Med Microbiol (2014) 0.81
Heparin-binding motifs and biofilm formation by Candida albicans. J Infect Dis (2013) 0.81
Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother (2016) 0.79
Prevention of catheter-related bacteremia in children on hemodialysis: time for action. Pediatr Nephrol (2009) 0.79
In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. Antimicrob Agents Chemother (2016) 0.78
Antibacterial synergy of glycerol monolaurate and aminoglycosides in Staphylococcus aureus biofilms. Antimicrob Agents Chemother (2014) 0.77
Hyaluronan Modulation Impacts Staphylococcus aureus Biofilm Infection. Infect Immun (2016) 0.76
The Natural Surfactant Glycerol Monolaurate Significantly Reduces Development of Staphylococcus aureus and Enterococcus faecalis Biofilms. Surg Infect (Larchmt) (2015) 0.75
Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol. PLoS One (2016) 0.75
Heparin-benzyl alcohol enhancement of biofilms formation and antifungal susceptibility of vaginal Candida species isolated from pregnant and nonpregnant Saudi women. Bioinformation (2013) 0.75
Streptokinase Treatment Reverses Biofilm-Associated Antibiotic Resistance in Staphylococcus aureus. Microorganisms (2016) 0.75
Heparin Mimics Extracellular DNA in Binding to Cell Surface-Localized Proteins and Promoting Staphylococcus aureus Biofilm Formation. mSphere (2017) 0.75
Effect of silver nanocoatings on catheters for haemodialysis in terms of cell viability, proliferation, morphology and antibacterial activity. J Mater Sci Mater Med (2013) 0.75
A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother (2017) 0.75
Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol (1951) 28.27
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22
MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol (1994) 7.14
sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol (2002) 6.71
Staphylococcus and biofilms. Mol Microbiol (2002) 6.39
Intravascular-catheter-related infections. Lancet (1998) 4.99
Global gene expression in Staphylococcus aureus biofilms. J Bacteriol (2004) 4.46
Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis (2000) 4.19
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun (1996) 3.95
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev (1991) 3.93
Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb Pathog (1986) 3.87
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol (1998) 3.79
Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun (2003) 3.77
Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol (1976) 3.64
Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol (2004) 3.58
Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol (2002) 3.57
Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr. J Bacteriol (1994) 3.54
SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol (2003) 3.46
Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J Bacteriol (2004) 3.45
The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun (1998) 3.44
The sporulation transcription factor Spo0A is required for biofilm development in Bacillus subtilis. Mol Microbiol (2001) 3.24
Sigma(B) activity depends on RsbU in Staphylococcus aureus. J Bacteriol (2001) 3.16
Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J Bacteriol (2001) 2.89
Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 2.79
Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol (2000) 2.78
Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene. Eur J Biochem (1991) 2.71
Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect Immun (2001) 2.49
Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol (1999) 2.23
Acute septic arthritis. Clin Microbiol Rev (2002) 2.17
Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol (2001) 2.01
Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect (2002) 2.01
Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem (1997) 2.01
Alpha-toxin is required for biofilm formation by Staphylococcus aureus. J Bacteriol (2003) 1.73
Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson. Int J Med Microbiol (2004) 1.57
Susceptibility of biofilms to Bdellovibrio bacteriovorus attack. Appl Environ Microbiol (2005) 1.55
Molecular mechanisms of Staphylococcus epidermidis biofilm formation. J Hosp Infect (1999) 1.52
In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother (2003) 1.45
Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother (2002) 1.37
Molecular cloning and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus. J Biol Chem (1996) 1.36
Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts. Infect Immun (2002) 1.33
Consequences of intravascular catheter sepsis. Clin Infect Dis (1993) 1.29
Binding of heparan sulfate to Staphylococcus aureus. Infect Immun (1992) 1.24
Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis. Infect Immun (1999) 1.21
Transduction analysis of transposon Tn551 insertions in the trp-thy region of the Staphylococcus aureus chromosome. J Bacteriol (1984) 1.18
Evolution of glycosaminoglycans and their glycosyltransferases: Implications for the extracellular matrices of animals and the capsules of pathogenic bacteria. Anat Rec (2002) 1.17
Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model. Infect Immun (1989) 1.14
Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother (1988) 1.07
Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs (1998) 1.04
Confocal laser scanning microscopy of peritoneal catheter surfaces. J Med Microbiol (1993) 1.02
Simple method for measuring the antibiotic concentration required to kill adherent bacteria. Chemotherapy (1992) 1.00
Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur J Biochem (2003) 0.96
Identification of the sigB operon in Staphylococcus epidermidis: construction and characterization of a sigB deletion mutant. Infect Immun (2001) 0.92
Influences of sigmaB and agr on expression of staphylococcal enterotoxin B (seb) in Staphylococcus aureus. Can J Microbiol (2004) 0.91
Role of heparan sulfate in interactions of Listeria monocytogenes with enterocytes. Med Microbiol Immunol (2003) 0.88
An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters. J Antimicrob Chemother (2002) 0.86
Eukaryotic cell uptake of heparin-coated microspheres: a model of host cell invasion by Chlamydia trachomatis. Infect Immun (2000) 0.82
Isolation and characterisation of a 17-kDa staphylococcal heparin-binding protein with broad specificity. J Med Microbiol (2001) 0.81
The role of glycosaminoglycan binding of staphylococci in attachment to eukaryotic host cells. Curr Microbiol (2001) 0.80
A particle agglutination assay for rapid identification of heparin binding to coagulase-negative staphylococci. J Med Microbiol (1996) 0.80
Adherence of coagulase-negative staphylococci to heparin and other glycosaminoglycans immobilized on polymer surfaces. J Biomed Mater Res (1994) 0.79
Thrombosis of a mitral valve prosthesis resulting from Staphylococcus epidermidis endocarditis. Cardiologia (1999) 0.78
Bacterial binding to extracellular matrix proteins -- in vitro adhesion. APMIS (1999) 0.77
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature (2003) 6.06
MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity (2006) 4.28
Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl Environ Microbiol (2006) 3.51
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest (2010) 3.40
Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol (2003) 3.37
An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med (2003) 3.32
Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. J Bacteriol (2008) 3.32
A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J Bacteriol (2005) 3.05
Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci U S A (2003) 3.02
Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol (2010) 2.98
Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescens WCS365 requires an ABC transporter and a large secreted protein. Mol Microbiol (2003) 2.95
Growing and analyzing static biofilms. Curr Protoc Microbiol (2005) 2.91
LapD is a bis-(3',5')-cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas fluorescens Pf0-1. Proc Natl Acad Sci U S A (2009) 2.60
Inverse regulation of biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J Bacteriol (2007) 2.55
BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J Bacteriol (2007) 2.49
SadB is required for the transition from reversible to irreversible attachment during biofilm formation by Pseudomonas aeruginosa PA14. J Bacteriol (2004) 2.48
The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol (2008) 2.47
Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog (2009) 2.37
Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol (2007) 2.32
SadC reciprocally influences biofilm formation and swarming motility via modulation of exopolysaccharide production and flagellar function. J Bacteriol (2007) 2.29
The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends Microbiol (2009) 2.23
The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol (2012) 2.22
Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe (2008) 2.20
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol (2013) 2.17
Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis (2007) 2.13
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol (2011) 2.09
A c-di-GMP effector system controls cell adhesion by inside-out signaling and surface protein cleavage. PLoS Biol (2011) 2.05
Non-identity-mediated CRISPR-bacteriophage interaction mediated via the Csy and Cas3 proteins. J Bacteriol (2011) 2.02
Phosphate-dependent modulation of c-di-GMP levels regulates Pseudomonas fluorescens Pf0-1 biofilm formation by controlling secretion of the adhesin LapA. Mol Microbiol (2007) 1.98
Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis. PLoS Biol (2011) 1.93
Evidence for two flagellar stators and their role in the motility of Pseudomonas aeruginosa. J Bacteriol (2005) 1.86
Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun (2009) 1.86
The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. Infect Immun (2007) 1.78
Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol (2008) 1.77
The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol (2011) 1.76
Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant (2006) 1.75
Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther (2008) 1.72
Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis (2006) 1.68
In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun (2008) 1.61
Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria. Nat Chem Biol (2009) 1.61
Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed (2012) 1.59
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest (2003) 1.56
Biofilm formation by Pseudomonas fluorescens WCS365: a role for LapD. Microbiology (2006) 1.56
Susceptibility of biofilms to Bdellovibrio bacteriovorus attack. Appl Environ Microbiol (2005) 1.55
Second messenger regulation of biofilm formation: breakthroughs in understanding c-di-GMP effector systems. Annu Rev Cell Dev Biol (2012) 1.54
Specific control of Pseudomonas aeruginosa surface-associated behaviors by two c-di-GMP diguanylate cyclases. MBio (2010) 1.52
Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus. J Bacteriol (2004) 1.52
A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One (2010) 1.52
Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect Immun (2005) 1.52
Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog (2012) 1.52
Cyclic-di-GMP-mediated repression of swarming motility by Pseudomonas aeruginosa: the pilY1 gene and its impact on surface-associated behaviors. J Bacteriol (2010) 1.50
Conservation of the Pho regulon in Pseudomonas fluorescens Pf0-1. Appl Environ Microbiol (2006) 1.50
Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis (2002) 1.49
Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol (2013) 1.48
Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J Bacteriol (2011) 1.48
sarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus. Infect Immun (2003) 1.48
Characterization of MazFSa, an endoribonuclease from Staphylococcus aureus. J Bacteriol (2007) 1.47
SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development. J Bacteriol (2005) 1.45
Isolation and characterization of a generalized transducing phage for Pseudomonas aeruginosa strains PAO1 and PA14. J Bacteriol (2004) 1.45
Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: new role for the NADPH oxidase in host defense. Proc Natl Acad Sci U S A (2004) 1.42
Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging. J Invest Dermatol (2008) 1.42
A recA-LexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus. J Biol Chem (2003) 1.41
New yeast recombineering tools for bacteria. Plasmid (2009) 1.39
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol (2009) 1.36
Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol (2005) 1.35
Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect Immun (2005) 1.35
Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study. J Orthop Res (2011) 1.34
SarA positively controls bap-dependent biofilm formation in Staphylococcus aureus. J Bacteriol (2005) 1.28
Cif is negatively regulated by the TetR family repressor CifR. Infect Immun (2008) 1.27
Systematic analysis of diguanylate cyclases that promote biofilm formation by Pseudomonas fluorescens Pf0-1. J Bacteriol (2011) 1.27
Impacts of sarA and agr in Staphylococcus aureus strain Newman on fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis. Infect Immun (2004) 1.25
The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect Immun (2011) 1.25
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea (2012) 1.23
Structural and function analyses of the global regulatory protein SarA from Staphylococcus aureus. Proc Natl Acad Sci U S A (2006) 1.23
A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog (2011) 1.22
The expression of alpha-haemolysin is required for Staphylococcus aureus phagosomal escape after internalization in CFT-1 cells. Cell Microbiol (2008) 1.22
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis (2012) 1.22
Proteolytic regulation of toxin-antitoxin systems by ClpPC in Staphylococcus aureus. J Bacteriol (2009) 1.21
Overexpression of MazFsa in Staphylococcus aureus induces bacteriostasis by selectively targeting mRNAs for cleavage. J Bacteriol (2009) 1.21
SarT influences sarS expression in Staphylococcus aureus. Infect Immun (2003) 1.20
Vulnerability of pathogenic biofilms to Micavibrio aeruginosavorus. Appl Environ Microbiol (2006) 1.20
Rapid response to a conjunctivitis outbreak: the use of technology to leverage information. J Am Coll Health (2002) 1.19
Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model. Microb Pathog (2002) 1.18
Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J Infect Dis (2009) 1.18
Regulation of the mazEF toxin-antitoxin module in Staphylococcus aureus and its impact on sigB expression. J Bacteriol (2009) 1.18
Fibrinogen depletion attenuates Staphyloccocus aureus infection by preventing density-dependent virulence gene up-regulation. J Immunol (2003) 1.15
Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus. J Bacteriol (2011) 1.14
Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun (2010) 1.14
Expression of SarX, a negative regulator of agr and exoprotein synthesis, is activated by MgrA in Staphylococcus aureus. J Bacteriol (2006) 1.14
Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillin-resistant Staphylococcus aureus strain USA300. Infect Immun (2010) 1.13
Modulation of Pseudomonas aeruginosa surface-associated group behaviors by individual amino acids through c-di-GMP signaling. Res Microbiol (2011) 1.13
Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother (2011) 1.12
Transcriptional regulation of the agr locus and the identification of DNA binding residues of the global regulatory protein SarR in Staphylococcus aureus. Mol Microbiol (2006) 1.12
In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J Bacteriol (2007) 1.11
SarZ promotes the expression of virulence factors and represses biofilm formation by modulating SarA and agr in Staphylococcus aureus. Infect Immun (2008) 1.10